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OBJECTIVES We investigated possible differences between male and female patients regarding ablation
therapy.
BACKGROUND Gender-related differences might have a major impact on different aspects of radiofrequency
ablation therapy. Data on this topic are very limited, focusing almost exclusively on success
and recurrence rates.
METHODS The study population consisted of 894 consecutive patients who underwent catheter ablation
of accessory pathways (n  519) and/or atrioventricular nodal re-entrant tachycardia
(AVNRT) (n  379). There were 418 (46.8%) male and 476 (53.2%) female patients.
RESULTS Female patients were referred for ablation later than male patients (185  143 vs. 157  144
months after onset of symptoms, p 0.001) and after having been given more antiarrhythmic
drugs (1.6  1.2 vs. 1.3  1.1, p  0.001). Women were more symptomatic, with a higher
number of patients having 1 tachycardia episode per month (80.3% vs. 70.3% in men, p 
0.001). Fluoroscopy time, radiofrequency applications, and procedure duration were similar in
male and female patients undergoing accessory pathway ablation as well as in male and female
patients undergoing AVNRT ablation. No difference was seen in success, complication, and
recurrence rates between men and women.
CONCLUSIONS Physicians and/or patients tend toward a more conservative approach in female patients.
Women are referred for ablation later than are men, after a longer duration of symptoms, and
after having been given more antiarrhythmic drugs. However, potential concerns on behalf of
physicians or female patients do not seem to be justified: ablation procedures in women had
equally high success, low complication, and low recurrence rates as those procedures in male
patients. (J Am Coll Cardiol 2003;42:1103–7) © 2003 by the American College of
Cardiology Foundation
Radiofrequency catheter ablation provides curative treat-
ment with excellent success and minimal complication rates
for patients with supraventricular reentrant tachycardia
(1–4). Therefore, in the present day it represents a treat-
ment modality of first choice for these patients. Despite the
high numbers of procedures performed worldwide, pub-
lished reports contain only few data regarding potential
gender-related differences, focusing almost exclusively on
success and recurrence rates (4–6). However, differences
between male and female patients might have a major
impact on different aspects of ablation therapy.
Women have smaller heart size and smaller coronary
artery diameter than men (7–10). Such anatomical gender
differences have been considered to be one of the possible
factors explaining the findings of previous investigations
reporting a worse outcome of coronary artery bypass
grafting (CABG) but also coronary intervention in fe-
male patients (9,11–14). Radiofrequency ablation is
based on catheter manipulation inside the heart cham-
bers. Therefore, smaller chamber size in women could in
theory affect the ease of performance of ablation proce-
dures as well as their outcome, including success and
complication rates.
For male and female patients, different referral and
treatment policies with a more conservative management
approach and a potential underuse of medical resources in
women have been demonstrated in various fields of medi-
cine and cardiology (15–23). Previous studies have reported
that women with coronary artery disease (CAD) undergo
fewer major diagnostic procedures and are referred for
coronary revascularization less often and later in the course
of their disease, having more severe coronary symptoms
than men at the time of referral (15–18). Other investiga-
tions have shown that women with acute myocardial infarc-
tion (MI) have a longer prehospital delay, receive reperfu-
sion therapy less often, and undergo less noninvasive and
invasive procedures than men (19–22). Similar differences
have also been reported in other fields of medicine (23). As
for radiofrequency catheter ablation, there are no reports
addressing this issue.
The aim of this study was to investigate possible gender-
related differences in a large series of patients undergoing
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radiofrequency ablation of accessory pathways or atrioven-
tricular nodal re-entrant tachycardia (AVNRT).
METHODS
Study patients. The study population consisted of 894
consecutive patients who underwent catheter ablation of
accessory pathways (n  519, 58.1%) and/or AVNRT (n 
379, 42.4%) during a 43-month period in the Department
of Cardiology at the University of Muenster in Germany.
Four patients underwent both accessory pathway and
AVNRT ablation.
Of these 894 patients, 418 (46.8%) were male and 476
(53.2%) female. Accessory pathway ablation was performed
in 296 of 418 (70.8%) male and in 223 of 476 (46.8%)
female patients (p  0.001). The AVNRT ablation was
performed in 124 (29.7%) male and in 255 (53.6%) female
patients (p  0.001).
Radiofrequency ablation. Patients gave written informed
consent before the procedure. The radiofrequency catheter
ablation techniques we used have been described in detail
previously (24,25). In brief, the retrograde aortic approach
via the femoral artery was used for left-sided accessory
pathways. Right-sided accessory pathways were approached
via the femoral veins. Slow pathway ablation was performed
for ablation of AVNRT. Temperature-guided energy appli-
cation was used. Patients were monitored for 36 to 48 h
after the procedure. A 12-lead electrocardiogram (ECG)
was obtained before discharge.
The reported radiation dose is the dose-area product as
measured by a dose-area product meter (Diamentor D,
PTW, Freiburg, Germany).
Follow-up. The patients were seen 6 and 12 months after
ablation in the hospital or by the referring physician.
Furthermore, patient reports concerning clinical course,
symptoms, and medication, as well as ECGs, were regularly
sent to us by the referring physicians. Because the great
majority of the patients were referred by regularly referring
physicians, mostly cardiologists practicing in Muenster and
its environs, such follow-up data could be obtained for most
patients.
Statistical analysis. Data are presented as mean  1 SD.
To evaluate differences between male and female patients,
the chi-square test was used for dichotomous variables.
Continuous variables were compared by the Mann-Whitney
Rank Sum test. A p value of 0.05 was considered
significant. Analyses were performed with the software
package SigmaStat version 2.0 (SPSS Science, Chicago,
Illinois).
RESULTS
Anamnestic data. Patient characteristics are given in Table
1. In brief, female patients were referred for ablation on an
average of 28 months later after onset of symptoms than
male patients, and after having been given more antiar-
rhythmic drugs. In addition, female patients were more
symptomatic, with a higher number of patients having
frequent tachycardia episodes (more than one episode per
month) at the time of referral. Heart rate during tachycardia
was slightly higher in women. Symptom duration before
ablation was defined as time interval from the first reported
symptoms.
Symptom duration before ablation was shorter in younger
than in older patients and was significantly shorter in male
than in female patients in both age groups: 100  88
months in male (n  178) versus 125  93 months in
female (n 207) patients40 years of age (p 0.005); 199
 161 months in men (n  240) versus 230  156 months
in women (n  269) 40 years of age (p  0.015).
We also compared symptom duration and number of
antiarrhythmic drugs in men and women separately in two
groups: in patients with pre-excitation in the resting ECG
(i.e., with overt accessory pathways) and in patients without
pre-excitation in the resting ECG. This second group
contained the patients with concealed accessory pathways
and the patients with AVNRT. In the first group (with
pre-excitation), symptom duration was 161  150 months
in men (n 222) versus 176 145 months in women (n
161), p  NS; number of antiarrhythmic drugs before
ablation was 1.0  1.0 in men versus 1.4  1.1 in women
(p  0.002). In the second group (without pre-excitation),
symptom duration was 154  137 months in male (n 
196) versus 189  141 in female (n  315) patients, p 
0.002; number of antiarrhythmic drugs was 1.5  1.2 in
men versus 1.6  1.3 in women, p  NS.
Abbreviations and Acronyms
AV  atrioventricular
AVNRT  atrioventricular nodal re-entrant tachycardia
CABG  coronary artery bypass grafting
CAD  coronary artery disease
ECG  electrocardiogram
MI  myocardial infarction
Table 1. Patient Characteristics
Male
(n  418)
Female
(n  476) p Value
Age (yrs) 43  15 (6–82) 43  15 (13–76) NS
Symptom duration before
ablation (months)
157  144 185  143 0.001
No. of antiarrhythmic
drugs before ablation
1.3  1.1 1.6  1.2 0.001
No. of patients with 1
tachycardia episode per
month
294 (70.3) 382 (80.3) 0.001
Heart rate during
tachycardia (beats/min)
182  27 189  31 0.001
Data are expressed as number (%) of patients or mean value  SD; range is given in
parentheses.
NS  not significant.
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Procedure-related parameters and outcome. The number
of ablation procedures performed was 997: 474 in male and
523 in female patients.
Procedure-related parameters are given in Table 2. Flu-
oroscopy time, number of radiofrequency applications, and
procedure duration were similar in male and female subjects
undergoing accessory pathway ablation as well as in male
and female subjects undergoing AVNRT ablation. Owing
to the higher proportion of AVNRT as underlying arrhyth-
mia in women, female patients required a shorter fluoros-
copy time and procedure duration and fewer energy appli-
cations in the total study population. Radiation dose was
significantly lower in women.
The number of different ablation catheters used per
procedure was also significantly lower in female patients (1.3
 0.6 vs. 1.5  0.8 in male patients, p  0.04).
Success and complications. Success rates were similar in
male and female patients. In the total study population,
ablation success was achieved in 390 (93%) male and 452
(95%) female patients (p  NS). To achieve these success
rates, up to two additional ablation procedures were per-
formed in 15 (3.6%) male and 16 (3.4%) female patients (p
 NS). There was also no difference in success rates
between men and women in patients with accessory path-
way and with AVNRT ablation: in patients with accessory
pathways, catheter ablation was successful in 271 (92%)
male and 205 (92%) female patients (p  NS); in patients
with AVNRT, successful ablation was performed in 121
(98%) male and 248 (97%) female patients (p  NS).
No procedure-related deaths occurred. Complication
rates were similar in men and women. There were 38 (8.0%)
complications in procedures performed in male patients and
54 (10.3%) in female patients (p  NS). These were of
minor importance in most cases, including transient com-
plete atrioventricular (AV) block, new bundle branch block,
transient completely reversible neurological symptoms
(hemianopsia, central scotoma, disorientation, etc.), femoral
nerve paralysis, vascular complications (arteriovenous fistula,
pseudoaneurysm), minor pericardial effusion not requiring
treatment, conservatively treated retroperitoneal hematoma,
and conservatively treated extensive groin hematoma.
Major complications included AV block with permanent
pacemaker implantation, cardiac tamponade, left ventricular
perforation necessitating surgical repair, cerebral infarction,
and conservatively treated aortic dissection. No difference
existed in the rate of major complications in procedures
performed in male (n  5, 1.1%) and female (n  6, 1.1%)
patients (p  NS).
Recurrences. Follow-up duration was 7.9  5.5 months
(range 1 to 36 months). Recurrence rates during follow-up
were similar in men and women. In the total study popu-
lation, recurrences after successful ablation occurred in 39
(10.0%) male and 33 (7.3%) female patients (p  NS).
There was also no difference in recurrence rates between
men and women in patients with accessory pathway and
patients with AVNRT ablation: in patients with accessory
pathways, recurrence was observed in 29 (10.7%) male and
21 (10.2%) female patients (p  NS); in patients with
AVNRT ablation, recurrence occurred in 10 (8.3%) male
and 12 (4.8%) female patients (p  NS).
DISCUSSION
The present study demonstrates significant gender differ-
ences in the referral policy for radiofrequency catheter
ablation therapy. Female patients are referred for ablation
later than male patients are (i.e., after a significantly longer
duration of symptoms, after having been given more anti-
arrhythmic drugs, and with more severe symptoms). The
outcome is the same in both genders, with no difference in
success, complication, and recurrence rates.
Currently, catheter ablation therapy is treatment modality
of first choice for symptomatic patients with supraventric-
ular reentrant tachycardia. Numerous previous reports have
proven the excellent results of this therapy form, with high
success, low complication, and low recurrence rates (1–
6,24–26). These reports have shown that there is no
difference in success, complication, and recurrence rates
between men and women (4–6). However, almost no data
exist on possible gender-related differences in other aspects
of ablation therapy. To the best of our knowledge, our study
is the first to investigate these differences.
The reason why physicians are more unwilling to refer
female patients rather than male patients is not completely
evident. A possible explanation would be a higher degree of
concerns about potential consequences of radiation exposure
in women. Considering the relatively high proportion of
young patients among subjects presenting with supraven-
tricular reentrant tachycardia, these concerns could also
regard reproduction-associated consequences. Previous re-
Table 2. Procedure Parameters
Accessory Pathway Ablations AVNRT Ablations Total Ablations
Male
(n  345)
Female
(n  258) p
Male
(n  132)
Female
(n  270) p
Male
(n  474)
Female
(n  523) p
Fluoroscopy time (min) 46.8  45.2 43.8  35.2 NS 27.5  26.2 28.3  43.0 NS 41.4  41.7 35.7  40.3 0.001
Radiation dose (cGy  cm2) 4,731  5,331 3,601  3,564 0.01 2,717  2,336 2,108  2,435 0.001 4,157  4,766 2,842  3,139 0.001
No. of RF applications 5.1  5.3 4.3  4.1 NS 3.3  3.0 3.2  3.3 NS 4.6  4.8 3.7  3.7 0.007
Procedure duration (min) 185  94 197  124 NS 138  74 130  68 NS 170  91 161  103 0.03
Data refer to ablation procedures and are expressed as mean value  SD.
AVNRT  atrioventricular nodal re-entrant tachycardia; NS  not significant; RF  radiofrequency.
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ports also suggest that symptoms of paroxysmal supraven-
tricular tachycardia are more likely to be attributed to panic,
anxiety, or stress in women than in men, thus delaying the
diagnosis of supraventricular tachycardia (27). It may also be
that women do prefer not to undergo procedures for the
following reasons: concerns about safety or because they
suffer less than men; are able to tolerate a similar degree of
incapacitation more than men can; are more concerned
about who is taking care of their children; seeing themselves
as less important than men might see themselves.
However, potential concerns on behalf of physicians or
female patients do not seem to be justified by the further
results of our study. Ablation procedures in women had
equally excellent success and equally low recurrence rates
with those of men. Also, no differences existed in fluoros-
copy time, radiofrequency applications, and procedure du-
ration between male and female patients undergoing acces-
sory pathway ablation as well as between male and female
patients undergoing AVNRT ablation. In the total study
population, ablations in women had shorter fluoroscopy and
procedure times and fewer energy applications. This was
due to the higher proportion of AVNRT as underlying
arrhythmia in women, as AVNRT ablations were charac-
terized by shorter procedure and fluoroscopy duration and
less radiofrequency applications than were accessory path-
way ablations.
A factor that was found to affect delay in referral was the
presence of pre-excitation in the resting ECG. Differences
in symptom duration before ablation were mainly due to
later referral of women compared to men in patients without
pre-excitation, whereas no significant difference existed in
symptom duration between men and women exhibiting
pre-excitation in the resting ECG. A possible explanation
for this fact is that a delta wave is objective and in most cases
easily recognizable. This would possibly limit differences
between men and women in the time required to establish
the diagnosis and prevent attribution of symptoms to panic,
anxiety, or stress. Furthermore, the presence of a delta wave
would probably limit possible fear of AV block associated
with the ablation procedure. Such fear could be present in
patients with presumed diagnosis of AVNRT due to the
higher risk of AV block associated with AVNRT ablation
compared to pathway ablation.
A gender-related difference in radiation exposure with
higher radiation dose in men was also noted in a previous
report of Rosenthal et al. (28). Fluoroscopy duration in the
present study was similar to the one reported by Calkins et
al. (29) and Kalbfleisch et al. (3) and somewhat shorter than
that reported by Rosenthal et al. (28). Our data on proce-
dural outcome are similar with the success, complication,
and recurrence rates reported by previous studies (4–6,
26,30,31).
Anatomical gender differences could in theory affect
procedure outcomes. Earlier studies have shown that
women have a smaller heart size and smaller coronary artery
diameter (7–10). These differences are at least partially due
to the smaller body size of women (8,9). Together with a
higher frequency of comorbidities at presentation, they have
been considered to be one of the factors explaining findings
of previous studies reporting a worse outcome of CABG
surgery but also coronary intervention in female patients
(9,11–14). Radiofrequency ablation is based on catheter
manipulation inside the heart chambers. Therefore, smaller
chamber size in women could theoretically influence the
ease of performance of ablation procedures and, thus,
success and complication rates. Our findings did not con-
firm this hypothesis.
Although our findings are novel in the field of radiofre-
quency ablation of arrhythmias, they confirm several previ-
ous reports demonstrating a less aggressive approach and a
potential underuse of medical resources among female
patients in different fields of cardiology and in medicine in
general (15–23). Thus, it has been reported that women
with CAD undergo cardiac catheterization less often and
are referred for coronary revascularization less often and
later in the course of their disease than are men (15–18).
Other investigations have shown that women with acute MI
have a longer prehospital delay, a lower thrombolysis rate,
and undergo coronary angiography, coronary intervention,
and CABG less often than men (19–22). Such differences
are not confined to cardiology; they have also been reported
in other fields of medicine (23).
Study limitations. A limitation of the study is the retro-
spective collection of data. A further limitation is the fact
that we only included patients with accessory pathways and
AVNRT. This could limit the generalizability of our find-
ings to patients undergoing other ablation procedures.
We presented data on symptom duration before ablation.
Symptom duration was defined as the time interval from the
first reported symptoms. We do not have data on the time
interval from first diagnosis to ablation. Such data would
have been helpful in better characterization of referral delay
in women by differentiating between delay in diagnosis and
delay in referral for ablation after diagnosis.
Conclusions. Physicians and/or patients tend toward a
more conservative approach in female patients. Women are
referred for ablation later than are men, after a longer
duration of symptoms, and after having been given more
antiarrhythmic drugs. However, potential concerns on be-
half of physicians or female patients do not seem to be
justified: ablation procedures in women had equally high
success, low complication, and low recurrence rates as
procedures in male patients.
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